How young? I mean it makes sense, but the pandemic is turning to younger people. I've also heard cases are more often serious (I mean once someone is in hospital it's now more often that they get in intensive care, or they get there fewer days after admission).
This may have to do with the oldest groups being vaccinated. But they sometimes say it's the English variant (not definitive, I've heard contradictory reports). And I think live/job plays a role too, beyond the oldest groups more than age, just a more difficult criteria to use.
The other question is whether vaccinating young people can stop transmission (I'd say not so much, I don't know).
But yes, maybe we should push to vaccinate older people around the world before vaccinating the young anywhere.
I couldn't tell, I think we're going to keep vaccinating lots of people and changing vaccines as the virus changes without ever getting rid of it. Unless everybody starts locking down hard and then reopening without travel in or out, which most people seem to reject.
I don''t understand that either. I think it was 5 cases per million in the general population and 0.9 cases per million in J&J patients. That alone would seem to tell that J&J protects against thrombosis.
But as you say it depends which subgroups you look at. But how do they know which ones to look at ? And they must not know the platelet count for most of those 6,8 million vaccinated people, do they?
I guess that's why doctors spend time in University learning their things.
I also don't know whether the low platelet count before the injection is a cause for concern or whether whatever the platelet count, the injection may in rare cases cause both thrombosis and low platelet count (maybe it just uses up the platelets to build clots and leaves few platelets in the circulating blood??).
